GLP Watchdog

Docberry vs Hers

Hers has an open FDA warning letter dated September 9, 2025. Docberry has none. No price lines up like for like. They share compounded semaglutide injection, but Docberry's $199 comes with plan terms the seller's page leaves unclear.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Docberry / Hers

Docberry logo

Docberry

7.2/10

Hers logo

Hers

6.8/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$582/moCompounded tirzepatide injection
$199/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit DocberryFull review
Visit HersFull review

Neither Docberry nor Hers pays us. Links to them earn nothing. Scores: Docberry 7.2, Hers 6.8. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Docberry has none.

  2. 02

    Docberry names Olympia Pharmaceuticals, a 503A and 503B pharmacy. Hers names three pharmacies.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Docberry's $199 comes with plan terms the seller's page leaves unclear.

  4. 04

    Only Docberry lists a price for compounded tirzepatide injection. Only Hers lists a price for brand-name tirzepatide pen.

  5. 05

    Hers lists all 50 states. Docberry publishes no state list.

  6. 06

    Docberry does not state its cancellation terms; Hers states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Docberry

Hers

Compounded semaglutide injection

$199/mo

plan terms unclear; not compared

$199/mo

$2,388 a year

Compounded tirzepatide injection

$582/mo

$6,984 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Price includes
Clinician visits
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
Not stated
Yes, stated
Minimum term
Sold as fixed packages: semaglutide for 4 or 12 months, tirzepatide for 3 months
None
Refunds
FAQ: refund concerns are addressed "on a case-by-case basis"; no written refund policy is posted.
No refund guaranteed once the pharmacy has processed an order

Read off each seller’s own pages. Docberry: October 17, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Docberry

7.2/10
  • No FDA warning letter on record
  • Sells compounded tirzepatide injection, which Hers does not price
  • Price includes clinician visits
  • Publishes no state list
Visit Docberry

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which Docberry does not price
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

Docberry 7.2 · Hers 6.8 out of 10. Six weighted parts.

Value25%

5.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.0A
vs
B
7.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

5.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Docberry vs Hers: questions

Hers has an open FDA warning letter dated September 9, 2025. Docberry has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Docberry names Olympia Pharmaceuticals, a 503A and 503B pharmacy. Hers names three pharmacies.
No price lines up like for like. They share compounded semaglutide injection, but Docberry's $199 comes with plan terms the seller's page leaves unclear. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Docberry does not state its cancellation terms. Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
Neither Docberry nor Hers pays us. Links to them earn nothing. Scores: Docberry 7.2, Hers 6.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks